Bavarian Nordic

Showing 4 posts of 4 posts found.


Bavarian Nordic announces RSV vaccine did not meet all primary endpoints in phase 3 trial

July 25, 2023
Medical Communications Bavarian Nordic, Infections and infestations, RSV, Vaccine, clinical trial

Bavarian Nordic has announced that its phase 3 clinical trial of MVA-BN, its respiratory syncytial virus (RSV) vaccine candidate for …

Bavarian Nordic seals $539 million vaccine deal

October 3, 2017
Manufacturing and Production BARDA, Bavarian Nordic, biotech, drugs, pharma, pharmaceutical

Bavarian Nordic, a Danish biotech, has continued its partnership with the US government by agreeing a $539 million deal to …

Bavarian Nordic logo

Janssen and Bavarian Nordic to collaborate on HPV vaccine

December 23, 2015
Research and Development Bavarian Nordic, HPV, Janssen, Vaccine, human papillomavirus, prime boost

Janssen has announced a new collaboration and license agreement with Bavarian Nordic to develop a vaccine for chronic Human Papillomavirus …

Bavarian Nordic courting cancer vaccine backers

November 12, 2010
Research and Development, Sales and Marketing Bavarian Nordic, Dendreon, Prostvac, Provenge, TroVax, cancer vaccine, prostate cancer, prostate cancer vaccine, zibotentan

Danish biotech Bavarian Nordic is in ‘advanced discussions’ with a number of potential pharma partners for its phase II therapeutic …

Latest content